Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NTCB01-1 vs NTCB-P in Parenteral Nutrition
NCT06625931Phase 3Completed
- Sponsor
- Yuhan
- Start
- Nov 2024
- Primary completion
- Mar 2025
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of NTCB01-1 in Malnutrition (2 arms), sponsored by Yuhan. Primary endpoint: Occurrence rate of adverse drug reaction. Started Nov 2024; status: completed.
02
Drugs
NTCB01-1
03
Conditions
Malnutrition
Beyond the preview
Go deeper on NCT06625931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06625931.